Skip to main content

Medical Risk and Benefit in Renal Donors: The Use of Living Donors Is Justified

  • Conference paper
Organ Replacement Therapy: Ethics, Justice Commerce

Abstract

In today’s world of technomedicine, the key topics of discussion circle round molecular biology and organ replacement therapy. In organ replacement especially, two subjects always spark off the liveliest debates:

  1. 1

    the definition of death;

  2. 2

    the ethics of living donation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bay WH, Hebert LA (1987) The living donation in kidney transplantation. Ann Intern Med 106: 719–727.

    Google Scholar 

  2. Bonomini V, Gozzetti G (1990) Is living donation still justifiable? Nephrol Dial Transplant 5: 407–409.

    Google Scholar 

  3. Daar AS (1989) Ethical issues — A middle east perspective. Transplant Proc 21: 1402–1404.

    Google Scholar 

  4. Pope John Paul II (1990) L’Osservatore Romano, May 1st.

    Google Scholar 

  5. Pope John Paul II (1980) Speech to blood and organ donors. Rome, October 15th.

    Google Scholar 

  6. Pope Pius XI (1930) Litt. Encycl “Casti Connubi.” AAS 22: 565.

    Google Scholar 

  7. Roberts JP, Fryd DS, Ascher NLN, Migliori, Payne RWD, Dunn DD, Sutherland DER, Simmons RL, Najarian JS (1988) Living related kidneys continue to provide superior results over cadaveric kidneys in the cyclosporine era. Transplant Proc 20 [Suppl 1]: 26–27.

    Google Scholar 

  8. Spital A (1988) Living kidney donation: still worth the risk. Transplant Proc 20: 1051–1058.

    Google Scholar 

  9. Spital A, Spital M (1988) Living kidney donation, attitudes outside the transplant center. Arch Intern Med 148: 1077–1080.

    Article  Google Scholar 

  10. Starzl TE (1987) Living donors: con. Transplant Proc 19: 174–176.

    Google Scholar 

  11. Terasaki P, Mickey MR, Iwaki Y, Cicciarelli J, Cecka M, Cook D, Yuge J (1989) Long-term survival of kidney grafts. Transplant Proc 21: 615–617.

    Google Scholar 

  12. The Council of The Transplantation Society (1985) Commercialization in transplantation: the problems and some guidelines for practice Lancet 2: 715–716.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Bonomini, V. (1991). Medical Risk and Benefit in Renal Donors: The Use of Living Donors Is Justified. In: Land, W., Dossetor, J.B. (eds) Organ Replacement Therapy: Ethics, Justice Commerce. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76444-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76444-8_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76446-2

  • Online ISBN: 978-3-642-76444-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics